Related references
Note: Only part of the references are listed.Apoptotic cells induce dendritic cell-mediated suppression via interferon-γ-induced IDO
Charlotte A. Williams et al.
IMMUNOLOGY (2008)
Bioactive Food Components and Cancer Risk Reduction
Silvia D. Stan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Curcumin for chemoprevention of colon cancer
Jeremy James Johnson et al.
CANCER LETTERS (2007)
Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation
Sander W. Tas et al.
BLOOD (2007)
p-Coumaric acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells
Sang Il Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells
Hwa Jung Lee et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells
In Duk Jung et al.
FEBS LETTERS (2007)
(-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: Evidences for the COX-2 and STAT1 as potential targets
Young-Il Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene
Katrin Ramsauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
C Orabona et al.
BLOOD (2006)
The role of serine/threonine kinases in T-cell activation
Sharon A. Matthews et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
BB Aggarwal et al.
CLINICAL CANCER RESEARCH (2005)
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
D Braun et al.
BLOOD (2005)
Curcumin inhibits immunostimulatory function of dendritic cells:: MAPKs and translocation of NF-κB as potential targets
GY Kim et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase
AL Mellor et al.
INTERNATIONAL IMMUNOLOGY (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
New embo member's review - Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity
F Granucci et al.
EMBO JOURNAL (2003)
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo
A Wakkach et al.
IMMUNITY (2003)
The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens
GT Belz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
IL-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2,3-dioxygenase
U Grohmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-γ-activated human macrophages:: Posttranslational regulation by pyrrolidine dithiocarbamate
SR Thomas et al.
JOURNAL OF IMMUNOLOGY (2001)
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
U Grohmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Kinetics of dendritic cell activation:: impact on priming of TH1, TH2 and nonpolarized T cells
A Langenkamp et al.
NATURE IMMUNOLOGY (2000)
IFN-γ inhibits presentation of a tumor/self peptide by CD8α- dendritic cells via potentiation of the CD8α+ subset
U Grohmann et al.
JOURNAL OF IMMUNOLOGY (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
P Hwu et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
